Miromatrix Medical Inc. Quarterly Debt-to-equity in % from Q1 2022 to Q3 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Miromatrix Medical Inc. quarterly Debt-to-equity history and growth rate from Q1 2022 to Q3 2023.
  • Miromatrix Medical Inc. Debt-to-equity for the quarter ending September 30, 2023 was 32.8 %, a 98.7% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2023 32.8 +16.3 +98.7% Sep 30, 2023
Q2 2023 27.6 +14.7 +114% Jun 30, 2023
Q1 2023 24.2 +14.4 +147% Mar 31, 2023
Q4 2022 21 Dec 31, 2022
Q3 2022 16.5 Sep 30, 2022
Q2 2022 12.9 Jun 30, 2022
Q1 2022 9.8 Mar 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.